Yıl: 2021 Cilt: 30 Sayı: 3 Sayfa Aralığı: 224 - 229 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2021.4712 İndeks Tarihi: 27-10-2021

Long-Term Predictors of Mortality in Peritoneal Dialysis Patients

Öz:
Objective: Peritoneal dialysis (PD) is one of the essential treatments for end-stage renal disease. Cardiovascular diseaseand peritonitis are the most common causes of death among PD patients. This study aimed to explore the long-term mortality predictors of PD patients.Methods: One hundred forty-one PD patients were retrospectively included in the study. Patients were selected amongcases admitted to the PD outpatient clinic between January 2015 and November 2020. Clinical and laboratory findingsobtained at the first visit were recorded. Prevalence of all-cause mortality and associated prognostic factors were analyzed.Results: The mean age of the patients was 52.5 ± 15.2 years (range 19-86). Thirty-two patients (22.7%) died in the followup. Age, hemodialysis (HD) history, diabetes mellitus (DM), ultrafiltration, urine volume, glomerular filtration rate, and normalized protein catabolic rate in modified peritoneal equilibrium test were significantly different between survived andnon-survived patients. Non-survived patients had higher ferritin, C-reactive protein (CRP), and CRP to albumin ratio (CAR)(P: .003, P:<.001; P: <.001; respectively). The Cox regression analysis revealed that the presence of DM HR 95%CI: 3.755(1.703-8.280), P: .001, HD history HR 95%CI: 2.843 (1.291-6.263), P: .010, and higher CAR ratio HR 95% CI: 4.235 (1.857-9.662),P: .001 were independent predictors of all-cause mortality. ROC curve analysis demonstrated that CAR > 1.94 predicted allcause-mortality with 73% sensitivity and 71% specificity (AUC = 0.789, 95%CI: 0.697-0.881).Conclusion: The present study demonstrates that DM, HD history, and high CAR are independent predictors of all-causemortality among PD patients.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Li PK, Chow KM, Van de Luijtgaarden MWM, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90-103. [CrossRef]
  • 2. Genestier S, Hedelin G, Schaffer P, Faller B. Prognostic factors in CAPD patients: a retrospective study of a 10-year period. Nephrol Dial Transplant. 1995;10(10):1905-1911.
  • 3. Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238-3252. [CrossRef]
  • 4. Kendrick J, Teitelbaum I. Strategies for improving long-term survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5(6):1123-1131. [CrossRef]
  • 5. Ishii J, Takahashi H, Kitagawa F, et al. Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis. Circ J. 2015;79(3):656-663. [CrossRef]
  • 6. Park SH, Stenvinkel P, Lindholm B. Cardiovascular biomarkers in chronic kidney disease. J Ren Nutr. 2012;22(1):120-127. [CrossRef]
  • 7. Li W, Xiong L, Fan L, et al. Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients. BMC Nephrol. 2017;18(1):211. [CrossRef]
  • 8. Liu S, Qiu P, Luo L, et al. Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis. Ren Fail. 2020;42(1):600-606. [CrossRef]
  • 9. Utaş C., Turkish Multicenter Peritoneal Dialysis Study Group. Patient and technique survival on CAPD in Turkey. Perit Dial Int. 2001;21(6):602-606. [CrossRef]
  • 10. Unsal A, Koc Y, Basturk T, et al. Clinical outcomes and mortality in peritoneal dialysis patients: a 10-year retrospective analysis in a single center. Clin Nephrol. 2013;80(4):270-279. [CrossRef]
  • 11. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States renal data System 2006 annual data report. Am J Kidney Dis. 2007;49(1)(suppl 1):A6-7, S1. [CrossRef]
  • 12. Fu S, Chen J, Liu B, et al. Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients. BMC Nephrol. 2020;21(1):237. [CrossRef]
  • 13. Sakacı T, Ahbap E, Koc Y, et al. Clinical outcomes and mortality in elderly peritoneal dialysis patients. Clinics. 2015;70(5):363-368. [CrossRef]
  • 14. Park JY, Cho JH, Jang HM, et al. Survival predictors in anuric patients on peritoneal dialysis: A prospective, multicenter, propensity score-matched cohort study. PLoS One. 2018;13(4):e0196294. [CrossRef]
  • 15. Hur SM, Ju HY, Park MY, et al. Ferritin as a predictor of decline in residual renal function in peritoneal dialysis patients. Korean J Intern Med. 2014;29(4):489-497. [CrossRef]
  • 16. Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-773. [CrossRef]
  • 17. Hasuike Y, Nonoguchi H, Tokuyama M, et al. Pathological role of aminolevulinate in uremic patients. Ther Apher Dial. 2011;15(1):28- 33. [CrossRef]
  • 18. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl. 2002;61(80):99-102. [CrossRef]
  • 19. Wang AY, Woo J, Lam CW, et al. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol. 2003;14(7):1871-1879. [CrossRef]
  • 20. Chen T, Hassan HC, Qian P, Vu M, Makris A. High-sensitivity troponin T and C-reactive protein have different prognostic values in hemo- and peritoneal dialysis populations: a cohort study. J Am Heart Assoc. 2018;7(5):e007876. [CrossRef]
  • 21. Alves FC, Sun J, Qureshi AR, et al. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. PLoS One. 2018;13(1):e0190410. [CrossRef]
  • 22. Oh TK, Song IA, Lee JH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis. Sci Rep. 2018;8(1):14977. [CrossRef]
  • 23. Mao M, Wei X, Sheng H, et al. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol Lett. 2017;14(6):7417- 7424. [CrossRef]
  • 24. Qin G, Tu J, Liu L, et al. Serum albumin and C-reactive protein/ albumin ratio are useful biomarkers of Crohn’s disease activity. Med Sci Monit. 2016;22:4393-4400. [CrossRef]
  • 25. Moon JS, Ahn SS, Park YB, Lee SK, Lee SW. C-reactive protein to serum albumin ratio is an independent predictor of all-cause mortality in patients with ANCA-associated vasculitis. Yonsei Med J. 2018;59(7):865-871. [CrossRef]
  • 26. Liu S, Qiu P, Luo L, et al. Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis. Ren Fail. 2020;42(1):600-606. [CrossRef
APA ATAŞ D, AŞICIOĞLU E, Tugcu M, ARIKAN İ, VELİOĞLU A (2021). Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. , 224 - 229. 10.5152/turkjnephrol.2021.4712
Chicago ATAŞ Dilek Barutçu,AŞICIOĞLU Ebru,Tugcu Murat,ARIKAN İzzet Hakkı,VELİOĞLU Arzu Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. (2021): 224 - 229. 10.5152/turkjnephrol.2021.4712
MLA ATAŞ Dilek Barutçu,AŞICIOĞLU Ebru,Tugcu Murat,ARIKAN İzzet Hakkı,VELİOĞLU Arzu Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. , 2021, ss.224 - 229. 10.5152/turkjnephrol.2021.4712
AMA ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. . 2021; 224 - 229. 10.5152/turkjnephrol.2021.4712
Vancouver ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. . 2021; 224 - 229. 10.5152/turkjnephrol.2021.4712
IEEE ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A "Long-Term Predictors of Mortality in Peritoneal Dialysis Patients." , ss.224 - 229, 2021. 10.5152/turkjnephrol.2021.4712
ISNAD ATAŞ, Dilek Barutçu vd. "Long-Term Predictors of Mortality in Peritoneal Dialysis Patients". (2021), 224-229. https://doi.org/10.5152/turkjnephrol.2021.4712
APA ATAŞ D, AŞICIOĞLU E, Tugcu M, ARIKAN İ, VELİOĞLU A (2021). Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online), 30(3), 224 - 229. 10.5152/turkjnephrol.2021.4712
Chicago ATAŞ Dilek Barutçu,AŞICIOĞLU Ebru,Tugcu Murat,ARIKAN İzzet Hakkı,VELİOĞLU Arzu Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online) 30, no.3 (2021): 224 - 229. 10.5152/turkjnephrol.2021.4712
MLA ATAŞ Dilek Barutçu,AŞICIOĞLU Ebru,Tugcu Murat,ARIKAN İzzet Hakkı,VELİOĞLU Arzu Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online), vol.30, no.3, 2021, ss.224 - 229. 10.5152/turkjnephrol.2021.4712
AMA ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online). 2021; 30(3): 224 - 229. 10.5152/turkjnephrol.2021.4712
Vancouver ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A Long-Term Predictors of Mortality in Peritoneal Dialysis Patients. Turkish journal of nephrology (Online). 2021; 30(3): 224 - 229. 10.5152/turkjnephrol.2021.4712
IEEE ATAŞ D,AŞICIOĞLU E,Tugcu M,ARIKAN İ,VELİOĞLU A "Long-Term Predictors of Mortality in Peritoneal Dialysis Patients." Turkish journal of nephrology (Online), 30, ss.224 - 229, 2021. 10.5152/turkjnephrol.2021.4712
ISNAD ATAŞ, Dilek Barutçu vd. "Long-Term Predictors of Mortality in Peritoneal Dialysis Patients". Turkish journal of nephrology (Online) 30/3 (2021), 224-229. https://doi.org/10.5152/turkjnephrol.2021.4712